iBio (AMEX:IBIO) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 7.84 percent. This is a 76.09 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $100.000 thousand which beat the analyst consensus estimate of $25.000 thousand by 300.00 percent.